Sirinya Sitthirak
Nakhon Si Thammarat, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Divergent cGAS-STING-IRF3 signaling profiles mark the transition from precancerous biliary lesions to cholangiocarcinoma.
Journal: Experimental and molecular pathology
Published: February 09, 2026
Lipemic Plasma Identified Blood Donors: Triglyceride Variability and Exploratory Machine Learning Analysis.
Journal: Medical sciences (Basel, Switzerland)
Published: January 18, 2026
Conserved Phosphoprotein Networks Identify Actionable Adhesion/Wnt and Metallothionein Modules in Cholangiocarcinoma.
Journal: Medical sciences (Basel, Switzerland)
Published: December 24, 2025
Integrative Sequencing and Proteogenomic Approaches to Intratumoral Heterogeneity in Cholangiocarcinoma: Implications for Precision Diagnosis and Therapy.
Journal: Medical sciences (Basel, Switzerland)
Published: December 02, 2025
Network Pharmacology and Molecular Docking Identify Medicarpin as a Potent CASP3 and ESR1 Binder Driving Apoptotic and Hormone-Dependent Anticancer Activity.
Journal: International journal of molecular sciences
Published: November 04, 2025
Computational Investigation Identifies mTOR as a Primary Binding Target of Medicarpin in Cholangiocarcinoma: Insights from Network Pharmacology and Molecular Docking.
Journal: Life (Basel, Switzerland)
Published: October 31, 2025
LC-MS-based metabolomic characterization of Tinospora crispa extracts: impact of solvent selection on phytochemical composition and antioxidant properties.
Journal: RSC advances
Published: September 23, 2025
Prognostic value of cGAS-STING-IRF3 signaling in cholangiocarcinoma patients.
Journal: PloS one
Published: August 11, 2025
Response surface optimization of abiotic elicitors for betalain production and antioxidant capacity in Celosia argentea cell suspension cultures.
Journal: Scientific reports
Published: July 15, 2025
Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma.
Journal: Scientific reports
Published: January 05, 2025
Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling.
Journal: Anticancer research
Published: January 02, 2025
Last Updated: 09/26/2026